GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats

被引：31

作者：

Abaraviciene, Sandra Meidute ^{[1
,2
]}

Muhammed, Sarheed J. ^{[1
]}

Amisten, Stefan ^{[1
]}

Lundquist, Ingmar ^{[1
]}

Salehi, Albert ^{[1
]}

机构：

[1] Lund Univ, Div Islet Cell Physiol, SUS, Dept Clin Sci, S-22100 Lund, Sweden

[2] State Res Inst Ctr Innovat Vilnius, Dept Stem Cell Biol, Vilnius, Lithuania

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2013年 / 381卷 / 1-2期

关键词：

Obesity; Free fatty acid; Hormone secretion; Receptor; G-protein coupled receptor 40; DEPENDENT INSULIN-SECRETION; NITRIC-OXIDE SYNTHASE; BETA-CELL DYSFUNCTION; FATTY-ACID RECEPTOR; GLUCOSE; NO; IMPAIRMENT; IMPROVES; RELEASE;

D O I：

10.1016/j.mce.2013.07.025

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

The role of islet GPR40 protein in the pathogenesis of diabetes is unclear. We explored the influence of GPR40 protein levels on hormone secretion in islets from two rat models of spontaneous type 2 diabetes displaying either hyperlipidaemia or hyperglycaemia. GPR40 expression was analysed by confocal microscopy, Western blot and qPCR in islets from preobese Zucker (fa/fa) rats, diabetic Goto-Kakizaki (GK) rats, and controls. Confocal microscopy of control islets showed expression of GPR40 protein in insulin, glucagon and somatostatin cells. GPR40 expression was strongly increased in islets of hyperlipidaemic fa/fa rats and coincided with a concentration-related increase in palmitate-induced release of insulin and glucagon and its inhibition of somatostatin release. Conversely, hyperglycaemic GK islets displayed an extremely faint expression of GPR40 as did high-glucose-cultured control islets. This was reflected in abolished palmitate-induced hormone response in GK islets and high-glucose-cultured control islets. The palmitate antagonist rosiglitazone promoted reappearance of GPR40 in high-glucose-cultured islets and served as partial agonist in glucose-stimulated insulin release. GPR40 protein is abundantly expressed in pancreatic islets and modulates stimulated hormone secretion. Mild hyperlipidaemia in obesity-prone diabetes creates increased GPR40 expression and increased risk for an exaggerated palmitate-induced insulin response and lipotoxicity, a metabolic situation suitable for GPR40 antagonist treatment. Chronic hyperglycaemia creates abrogated GPR40 expression and downregulated insulin release, a metabolic situation suitable for GPR40 agonist treatment to avoid glucotoxicity. GPR40 protein is interactively modulated by both free fatty acids and glucose and is a promising target for pharmacotherapy in different variants of type 2 diabetes. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

页码：150 / 159

页数：10

共 34 条

[1]

Rosiglitazone counteracts palmitate-induced β-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities [J].

Abaraviciene, S. Meidute ;

Lundquist, I. ;

Salehi, A. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (14) :2256-2265

[2]

Palmitate-Induced β-Cell Dysfunction Is Associated with Excessive NO Production and Is Reversed by Thiazolidinedione-Mediated Inhibition of GPR40 Transduction Mechanisms [J].

Abaraviciene, Sandra Meidute ;

Lundquist, Ingmar ;

Galvanovskis, Juris ;

Flodgren, Erik ;

Olde, Bjorn ;

Salehi, Albert .

PLOS ONE, 2008, 3 (05)

[3]

Deletion of GPR40 Impairs Glucose-Induced Insulin Secretion In Vivo in Mice Without Affecting Intracellular Fuel Metabolism in Islets [J].

Alquier, Thierry ;

Peyot, Marie-Line ;

Latour, Martin G. ;

Kebede, Melkam ;

Sorensen, Christina M. ;

Gesta, Stephane ;

Kahn, C. Ronald ;

Smith, Richard D. ;

Jetton, Thomas L. ;

Metz, Thomas O. ;

Prentki, Marc ;

Poitout, Vincent .

DIABETES, 2009, 58 (11) :2607-2615

[4]

Amisten S, 2012, METHODS MOL BIOL, V788, P155, DOI 10.1007/978-1-61779-307-3_12

[5]

BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[6]

Differential effects of hyperlipidemia on insulin secretion in islets of Langerhans from hyperglycemic versus normoglycemic rats [J].

Briaud, I ;

Kelpe, CL ;

Johnson, LM ;

Tran, POT ;

Poitout, V .

DIABETES, 2002, 51 (03) :662-668

[7]

The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids [J].

Briscoe, CP ;

Tadayyon, M ;

Andrews, JL ;

Benson, WG ;

Chambers, JK ;

Eilert, MM ;

Ellis, C ;

Elshourbagy, NA ;

Goetz, AS ;

Minnick, DT ;

Murdock, PR ;

Sauls, HR ;

Shabon, U ;

Spinage, LD ;

Strum, JC ;

Szekeres, PG ;

Tan, KB ;

Way, JM ;

Ignar, DM ;

Wilson, S ;

Muir, AI .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11303-11311

[8]

The long-chain fatty acid receptor, GPR40, and glucolipotoxicity: investigations using GPR40-knockout mice [J].

Brownlie, Ruth ;

Mayers, Rachel M. ;

Pierce, Jackie A. ;

Marley, Anna E. ;

Smith, David M. .

BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 :950-954

[9]

G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids [J].

Del Guerra, S. ;

Bugliani, M. ;

D'Aleo, V. ;

Del Prato, S. ;

Boggi, U. ;

Mosca, F. ;

Filipponi, F. ;

Lupi, R. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (01) :22-25

[10]

β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death [J].

Finegood, DT ;

McArthur, MD ;

Kojwang, D ;

Thomas, MJ ;

Topp, BG ;

Leonard, T ;

Buckingham, RE .

DIABETES, 2001, 50 (05) :1021-1029

← 1 2 3 4 →